Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Sox9 and programming of liver and pancreatic progenitors
Yoshiya Kawaguchi
Yoshiya Kawaguchi
Published May 1, 2013
Citation Information: J Clin Invest. 2013;123(5):1881-1886. https://doi.org/10.1172/JCI66022.
View: Text | PDF
Review Series Article has an altmetric score of 3

Sox9 and programming of liver and pancreatic progenitors

  • Text
  • PDF
Abstract

Recent advances in developmental biology have greatly expanded our understanding of progenitor cell programming and the fundamental roles that Sox9 plays in liver and pancreas organogenesis. In the last 2 years, several studies have dissected the behavior of the Sox9+ duct cells in adult organs, but conflicting results have left unanswered the long-standing question of whether physiologically functioning progenitors exist in adult liver and pancreas. On the other hand, increasing evidence suggests that duct cells function as progenitors in the tissue restoration process after injury, during which embryonic programs are sometimes reactivated. This article discusses the role of Sox9 in programming liver and pancreatic progenitors as well as controversies in the field.

Authors

Yoshiya Kawaguchi

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 Total
Citations: 1 5 3 4 4 8 6 4 2 5 4 5 3 54
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2020 (8)

Title and authors Publication Year
Epithelial splicing regulatory protein 2-mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis
Jeongeun Hyun, Zhaoli Sun, Ali Reza Ahmadi, Sushant Bangru, Ullas V. Chembazhi, Kuo Du, Tianyi Chen, Hidekazu Tsukamoto, Ivan Rusyn, Auinash Kalsotra, Anna Mae Diehl
Journal of Clinical Investigation 2020
A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury
JY Kim, Y Bai, LA Jayne, RD Hector, AK Persaud, SS Ong, S Rojesh, R Raj, MJ Feng, S Chung, RE Cianciolo, JW Christman, MJ Campbell, DS Gardner, SD Baker, A Sparreboom, R Govindarajan, H Singh, T Chen, M Poi, K Susztak, SR Cobb, NS Pabla
Nature Communications 2020
MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity
E Liang, Y Lu, Y Shi, Q Zhou, F Zhi
Oncogene 2020
SOX9 promotes tumor progression through the axis BMI1-p21CIP
P Aldaz, M Otaegi-Ugartemendia, A Saenz-Antoñanzas, M Garcia-Puga, M Moreno-Valladares, JM Flores, D Gerovska, MJ Arauzo-Bravo, N Samprón, A Matheu, E Carrasco-Garcia
Scientific Reports 2020
Real‐time fluorometric evaluation of hepatoblast proliferation in vivo and in vitro using the expression of CYP3A7 coding for human fetus‐specific P450
S Okuyama, F Kawamura, M Kubiura, S Tsuji, M Osaki, H Kugoh, M Oshimura, Y Kazuki, M Tada
Pharmacology Research & Perspectives 2020
DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis
E Iguchi, A Takai, H Takeda, K Kumagai, S Arasawa, Y Eso, T Shimizu, Y Ueda, H Marusawa, H Seno
Scientific Reports 2020
Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer
LY Ding, YC Hou, IY Kuo, TY Hsu, TC Tsai, HW Chang, WY Hsu, CC Tsao, CC Tian, PS Wang, HC Wang, CT Lee, YC Wang, SH Lin, MW Hughes, WJ Chuang, PJ Lu, YS Shan, PH Huang
Clinical Epigenetics 2020
The local and circulating SOX9 as a potential biomarker for the diagnosis of primary bone cancer
A Hosseini, A Mirzaei, V Salimi, K Jamshidi, P Babaheidarian, S Fallah, Z Rampisheh, N Khademian, Z Abdolvahabi, M Bahrabadi, M Ibrahimi, F Hosami, M Tavakoli-Yaraki
Journal of Bone Oncology 2020

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
138 readers on Mendeley
1 readers on CiteULike
See more details